Clinicopathological characteristics, adjuvant chemotherapy decision and disease outcome in patients with breast cancer with a 21-gene recurrence score of 26–30

Recurrence score (RS) could be used to predict clinical outcomes and chemotherapy efficacy in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative and lymph node-negative breast cancer. However, the clinical features and management of patients with a...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jing, Wu, Jiayi, Huang, Ou, He, Jianrong, Zhu, Li, Chen, Weiguo, Li, Yafen, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377026/
https://www.ncbi.nlm.nih.gov/pubmed/32724396
http://dx.doi.org/10.3892/ol.2020.11734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7377026/
https://www.ncbi.nlm.nih.gov/pubmed/32724396
http://dx.doi.org/10.3892/ol.2020.11734

Ejemplares similares